Background illustration for clinical trials search

Paid Clinical Trials Oregon

Discover 1,087 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

for
Solid Tumors
Location: Boston MA, St. Petersburg FL, Germantown TN,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07415031

Phase 2, Recruiting
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Portland ME, Waterford CT, Manchester CT,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07496567

Phase 2, Phase 3, Recruiting
Active & Responsive

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

for
HR+ HER2- Breast Cancer
Location: Nashville TN, Austin TX, San Antonio TX, Lone Tree CO,
Sponsor: Faeth Therapeutics

Sex: All

Age: 18+

Code: NCT07558733

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

for
Multiple Myeloma in Relapse, Myeloma Multiple,
Location: Boston MA, Hackensack NJ, Tampa FL, Atlanta GA,
Sponsor: Kelonia Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07075185

Phase 1, Recruiting
Active & Responsive

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

for
Advanced Solid Tumors, Metastatic Solid Tumors,
Location: Norwich CT, New York NY, Hackensack NJ, Fairfax VA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07397338

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

for
Immune Thrombocytopenic Purpura (ITP)
Location: Boston MA, Portland OR
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06948318

Phase 3, Recruiting
Active & Responsive

FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors

for
Solid Tumor
Location: New Haven CT, Charleston SC, Denver CO, Portland OR
Sponsor: Axcynsis Therapeutics Pte Ltd

Sex: All

Age: 18+

Code: NCT06809114

Phase 1, Recruiting
Active & Responsive

Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

for
Hematopoietic and Lymphatic System Neoplasm
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06895473

Phase 2, Recruiting
Active & Responsive

Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial

for
Mantle Cell Lymphoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06357676

Phase 1, Phase 2, Recruiting
Active & Responsive

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

for
PIK3CA-related Overgrowth Spectrum (PROS)
Location: Washington D.C. DC, Chapel Hill NC, Pittsburgh PA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 70+

Code: NCT06997588

Phase 2, Recruiting
Active & Responsive

AMEND TS Early Feasibility Study

for
Symptomatic Functional MR 3 or Greater
Location: New York NY, Indianapolis IN, Houston TX,
Sponsor: Valcare Medical Ltd.

Sex: All

Age: 21+

Code: NCT06951672

Recruiting
Active & Responsive

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

for
AML With Gene Mutations
Location: New York NY, College Park MD, Chapel Hill NC,
Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All

Age: 18+

Code: NCT06366789

Phase 1, Recruiting
Active & Responsive

A Study of JNT-517 in Participants With Phenylketonuria (PKU)

for
Phenylketonuria
Location: Pittsburgh PA, Tampa FL, Gainesville FL, Nashville TN,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 4+

Code: NCT06971731

Phase 3, Recruiting
Active & Responsive

ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy

for
BAG3 Mutation Associated Dilated Cardiomyopathy
Location: Boston MA, Philadelphia PA, Cincinnati OH,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18 - 70

Code: NCT07218887

Phase 1, Phase 2, Recruiting
Active & Responsive

A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

for
Still´s Disease
Location: Toronto, Salt Lake City UT, Portland OR
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1+

Code: NCT07203001

Phase 2, Recruiting
Active & Responsive

CAN1012 in Pre-Malignant DCIS and LCIS

for
Ductal Carcinoma in Situ, Lobular Carcinoma in Situ
Location: Portland OR
Sponsor: Providence Health & Services

Sex: All

Age: 18+

Code: NCT07408856

Phase 1, Recruiting
Active & Responsive

Postural Motor Activation Deficits After mTBI; Translating Laboratory Findings to Clinical Care

for
Mild Traumatic Brain Injury (mTBI),
Location: Salt Lake City UT, Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 18 - 60

Code: NCT07549529

Recruiting
Active & Responsive

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin

for
Locally Advanced Hypopharyngeal Squamous Cell Carcinoma,
Location: Brewer ME, Stony Brook NY, The Bronx NY,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07441681

Phase 3, Recruiting
Active & Responsive

Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis

for
PARKINSON DISEASE (Disorder), Parkinson,
Location: Portland OR
Sponsor: CND Life Sciences

Sex: All

Age: 40 - 70+

Code: NCT07204652

Recruiting
Active & Responsive

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

for
REM Sleep Behavior Disorder
Location: Boston MA, North Haven CT, New York NY, Philadelphia PA,
Sponsor: Yale University

Sex: All

Age: 50 - 70+

Code: NCT06996652

Phase 2, Recruiting

Popular cities in Oregon